This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Castlight is Just the Beginning for These 2 Health Care Stocks

Stocks in this article: CSLT BNFT VEEV

NEW YORK ( TheStreet) -- We need only look to the IPO of Castlight Health (CSLT) on Friday to appreciate Wall Street's tremendous interest in stocks that help with health insurance. Castlight helps employers control heath care costs by providing complex data on from various internal an external sources.

Castlight surged 149% on March 14 despite revenue of less than $13 million in 2013. Shares were slipping 5.2% in mid-day trading on Monday brining the San Francisco-based company's market capitalization down to a slightly less eye-popping $3.3 billion.

The lofty valuation assigned to Castlight clearly indicates intense interest in the sector. With this in mind, we're looking at other health care stocks that could see nice upward action in the coming week.

Benefitfocus Inc (BNFT) offers solutions that enable employers and insurance carriers to shop, enroll, manage, and exchange benefits information. It offers various products for insurance carriers, including eEnrollment. Shares have been under pressure over the last week into the Castlight IPO, due mostly to the end of its own IPO lockup period.

This unlock of shares has attracted short sellers, but because of the huge success of the Castlight IPO, Benefitfocus appears poised for a rebound. As you can see from the chart below, Benefitfocus likes to trade very close to its 20-day moving average, currently sitting 10% higher at $63.13.

Benefitfocus always moves back to this moving average if it strays above or below it. The 50 day moving average at $65 would be second target for traders initiating a long position in the stock. Traders initiating a trade at Friday's close could use the recent low of $56.15 as stops for a downside risk of 82c. With $63.13 and $65 as targets on the trade this offers a very attractive risk/reward ratio of 7.5-10.




Veeva Systems Inc  (VEEV) helps life sciences companies in creating and maintaining a record of the healthcare professionals and healthcare organizations with which they interact. Veeva has also been under some downward pressure in recent days but again, given the huge market interest in the Castlight IPO, Veeva could see a nice bounce. With a forward PE of 98 the stock is not cheap but on its $210 million in annual revenues, when compared to the valuation Castlight is being afforded, shares could see buying pressure this week. More than half of Veeva's float is currently short, a potential powder-keg for a large short squeeze.

Traders looking for a trade in Veeva could consider a long entry on a break of the 20-day moving average at $33.73 with a $36 target followed by $38. Stops at the 50 day moving average at $33.03 gives a downside risk of 70c on the trade with a potential gain of $2.27 and $4.27.




At the time of publication, the author held no position in any of the other stocks mentioned. This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.

 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs